Skip to main content
    C

    Cencora Inc. (COR)

    Official site

    HEALTHCARE • MEDICAL DISTRIBUTION • NYSE

    $341.28
    +5.11 (+1.52%)

    Market Cap: $64.15B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    97%(38/39)
    Avg Surprise
    +5.08%
    Streak
    31 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$4.76
    Range$4.69 - $4.82
    14 analysts
    Revenue Consensus
    $85.7B
    Range$84.4B - $86.4B
    12 analysts
    Period ending Dec 31, 2026
    EPS Consensus$4.59
    Range$4.46 - $4.99
    7 analysts
    EPS Revisions
    1
    0
    7d
    3
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$4.50+2.0%
    60d ago$4.50+2.0%
    30d ago$4.56+0.7%
    7d ago$4.61-0.3%
    Current$4.59
    Revenue Consensus
    $89.4B
    Range$88.5B - $90.3B
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$4.59---
    Sep 26EST
    		-$4.76---
    Jun 26
    Reported Aug 5
    		$4.48$4.37+2.52%Beat+12.0%
    Mar 26
    Reported May 6
    		$4.75$4.73+0.42%Beat+7.5%
    Dec 25
    Reported Feb 4
    		$4.08$4.04+0.99%Beat+9.4%
    Sep 25
    Reported Nov 5
    		$3.84$3.79+1.32%Beat+15.0%
    Jun 25
    Reported Aug 6
    		$4.00$3.84+4.17%Beat+19.8%
    Mar 25
    Reported May 7
    		$4.42$4.10+7.80%Beat+16.3%
    Dec 24
    Reported Feb 5
    		$3.73$3.52+5.97%Beat+13.7%
    Sep 24
    Reported Nov 6
    		$3.34$3.22+3.73%Beat+16.8%
    Jun 24
    Reported Jul 31
    		$3.34$3.22+3.73%Beat+14.4%
    Mar 24
    Reported May 1
    		$3.80$3.69+2.98%Beat+8.6%
    Dec 23
    Reported Jan 31
    		$3.28$2.89+13.49%Beat+21.0%
    Sep 23
    Reported Nov 2
    		$2.86$2.81+1.78%Beat+10.0%
    Jun 23
    Reported Aug 2
    		$2.92$2.83+3.18%Beat+11.5%
    Mar 23
    Reported May 2
    		$3.50$3.30+6.06%Beat+8.7%
    Dec 22
    Reported Feb 1
    		$2.71$2.63+3.04%Beat+5.0%
    Sep 22
    Reported Nov 3
    		$2.60$2.57+1.17%Beat+8.8%
    Jun 22
    Reported Aug 3
    		$2.62$2.56+2.34%Beat+21.3%
    Mar 22
    Reported May 4
    		$3.22$2.92+10.27%Beat+27.3%
    Dec 21
    Reported Feb 2
    		$2.58$2.58+0.00%Beat+18.3%
    Sep 21
    Reported Nov 4
    		$2.39$2.36+1.27%Beat+26.5%
    Jun 21
    Reported Aug 4
    		$2.16$2.04+5.88%Beat+16.8%
    Mar 21
    Reported May 5
    		$2.53$2.46+2.85%Beat+5.4%
    Dec 20
    Reported Feb 4
    		$2.18$1.94+12.37%Beat+23.9%
    Sep 20
    Reported Nov 5
    		$1.89$1.87+1.07%Beat+17.4%
    Jun 20
    Reported Aug 5
    		$1.85$1.59+16.35%Beat+5.1%
    Mar 20
    Reported May 7
    		$2.40$2.27+5.73%Beat+13.7%
    Dec 19
    Reported Jan 30
    		$1.76$1.67+5.39%Beat+10.0%
    Sep 19
    Reported Nov 7
    		$1.61$1.58+1.90%Beat+11.0%
    Jun 19
    Reported Aug 1
    		$1.76$1.62+8.64%Beat+14.3%
    Mar 19
    Reported May 2
    		$2.11$1.96+7.65%Beat+8.8%
    Dec 18
    Reported Jan 31
    		$1.60$1.51+5.96%Beat+3.2%
    Sep 18
    Reported Nov 6
    		$1.45$1.46-0.68%Miss+9.0%
    Jun 18
    Reported Aug 2
    		$1.54$1.45+6.21%Beat+7.7%
    Mar 18
    Reported May 2
    		$1.94$1.82+6.59%Beat+9.6%
    Dec 17
    Reported Feb 6
    		$1.55$1.35+14.81%Beat+14.0%
    Sep 17
    Reported Nov 2
    		$1.33$1.32+0.76%Beat-
    Jun 17
    Reported Aug 3
    		$1.43$1.37+4.38%Beat-
    Mar 17
    Reported May 4
    		$1.77$1.68+5.36%Beat-
    Dec 16
    Reported Jan 31
    		$1.36$1.23+10.57%Beat-

    Dividends

    Dividend Metrics

    Forward Yield0.70%
    Forward Annual Dividend$2.40
    Payout Ratio9.62%
    FrequencyQuarterly
    Pay MonthsMar, Jun, Aug, Dec

    Growth

    3Y CAGR+6.46%
    5Y CAGR-19.34%
    COR dividend history and ex-dividend datesRun COR in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio19.90EV/EBITDA14.65x
    Price/FCF16.24xFCF Yield6.16%
    Profitability
    Profit Margin0.79%Operating Margin1.41%
    ROE96.90%ROIC20.00%
    Financial Health
    Debt/Equity3.84xInterest CoverageN/A
    Current Ratio0.93xQuick Ratio0.58x
    Trading Statistics
    Beta0.58Avg Volume1.26M
    52-Week High$375.3352-Week Low$243.78

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$323.54
    SMA 20$316.28
    SMA 50$319.85
    SMA 200$316.74
    EMA 10$326.16
    EMA 20$321.43
    EMA 50$316.97
    EMA 200$312.50

    MACD

    Line: 4.35Signal: 0.97Hist: 3.37

    ADX

    ADX: 19.6+DI: 36.0-DI: 14.7

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down56.0
    PSAR$313.49

    Bollinger Bands

    Upper Band$337.61
    Lower Band$294.95
    %B Position1349%(Upper)
    Band Width1.09

    RSI (14-Day)

    Overbought
    70.7

    Momentum Oscillators

    Stoch %K95.8
    Stoch %D95.0
    Williams %R-8.2
    ROC (10d)10.2%
    Momentum31.50
    CCI (20d)213.8
    MFI (14d)67.8

    Volatility Measures

    ATR (14d)$7.53(2.2%)
    StdDev (20d)10.67
    Hist Vol22.0%(Moderate)

    Volume Flow

    VWAP$342.01
    OBV14.4M
    AD Line-220.0M
    CMF (20d)0.141

    Volume Metrics

    Avg Vol (20d)1.3M
    Vol Ratio1.2x
    VWMA (20d)$315.09

    Pivot Points

    R3$343.57
    R2$339.95
    R1$338.06
    Pivot Point$334.44
    S1$332.55
    S2$328.93
    S3$327.04

    Advanced Oscillators

    TSI15.39
    Ultimate Osc63.9
    KST5.47

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$84.75B$78.36B$85.93B$83.73B$80.66B$75.45B$81.49B$79.05B$74.24B$68.41B$72.25B$68.92B
    Cost of Revenue$81.15B$74.77B$82.86B$80.77B$77.76B$72.39B$78.93B$76.56B$71.83B$65.88B$69.78B$66.67B
    Gross Profit$3.61B$3.59B$3.07B$2.95B$2.91B$3.06B$2.56B$2.49B$2.41B$2.54B$2.47B$2.25B
    Operating Expenses$2.49B$2.45B$2.31B$2.94B$2.04B$2.02B$1.85B$2.37B$1.74B$1.98B$1.65B$1.78B
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$2.13B$1.98B$1.80B$1.75B$1.67B$1.60B$1.47B$1.49B$1.38B$1.39B$1.40B$1.39B
    Operating Income$1.12B$1.14B$760.45M$18.50M$867.65M$1.04B$706.25M$126.64M$672.48M$553.26M$822.88M$476.94M
    Interest Income$-140,705,000$-140,460,000$-72,409,000$-77,833,000$-81,794,000$-103,988,000$-27,933,000$-20,969,000$-31,328,000$-64,130,000$-40,564,000$-60,942,000
    Interest Expense$123.82M$0$51.81M$205.55M$0$107.53M$85.81M$1.46M$44.14M$86.19M$39.48M$30.52M
    Income Before Tax$996.39M$2.09B$708.64M$-187,044,000$896.28M$928.66M$620.45M$125.18M$628.33M$467.07M$783.40M$446.42M
    Income Tax Expense$219.73M$459.04M$142.51M$146.03M$206.53M$211.24M$126.73M$117.71M$140.74M$45.86M$180.39M$97.44M
    Net Income$776.67M$1.63B$566.13M$-333,071,000$689.75M$717.42M$493.72M$7.47M$487.59M$421.20M$603.01M$348.98M
    EBITDA$1.41B$2.49B$1.05B$154.79M$1.24B$1.30B$929.85M$425.90M$940.55M$810.95M$1.10B$791.02M
    EBIT$1.14B$2.23B$781.05M$-109,211,000$978.07M$1.03B$648.38M$146.15M$659.66M$531.20M$823.96M$507.37M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about COR

    Government Contracts

    Gov Obligations (TTM)
    $2.80B
    Gov Obligations / Revenue
    0.9%
    Obligations YoY
    N/A
    Active Awards
    188,107
    New Awards (TTM)
    188,105
    Avg Remaining Term
    N/A

    Top agency: Department of Defense at 99.9% of trailing twelve month obligations across 3 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    SPE2DR26FTK1XDepartment of DefenseDefense Logistics Agency$9.01MMar 11, 2026
    SPE2DR26FTJ2ZDepartment of DefenseDefense Logistics Agency$7.74MJan 16, 2026
    SPE2D826F1G47Department of DefenseDefense Logistics Agency$5.18MFeb 18, 2026
    SPE2D826F0DPTDepartment of DefenseDefense Logistics Agency$4.93MFeb 3, 2026
    SPE2D826F10Z9Department of DefenseDefense Logistics Agency$4.79MFeb 18, 2026
    SPE2D826F09G3Department of DefenseDefense Logistics Agency$4.34MFeb 2, 2026
    SPE2D826F1C24Department of DefenseDefense Logistics Agency$4.20MFeb 3, 2026
    SPE2D826F09V0Department of DefenseDefense Logistics Agency$4.03MFeb 3, 2026
    SPE2D826F16P5Department of DefenseDefense Logistics Agency$3.98MApr 29, 2026
    SPE2D826F0Y96Department of DefenseDefense Logistics Agency$3.95MJan 14, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    McKesson stock: Leerink Partners raises target for McKesson stock to USD 1,070

    Leerink Partners has raised its price target for McKesson stock to $1,070 from $1,030, maintaining an outperform rating. McKesson's fiscal Q1 2027 revenue increased by 7.70% to $105.38 billion...

    ad-hoc-news.de•10/16/26•Neutral

    Baird lifts target for Cencora stock to USD 373.00

    Baird has raised its price target for Cencora stock from USD 370.00 to USD 373.00. The company reported fiscal third-quarter revenue of USD 84.75 billion, a 5.10% increase year-over-year...

    ad-hoc-news.de•10/16/26•Bullish

    Baird raises target for Cencora stock to USD 373.00

    Robert W. Baird has raised its target for Cencora stock from $370.00 to $373.00, maintaining an outperform rating. This adjustment follows Cencora's strong fiscal third-quarter results...

    ad-hoc-news.de•10/16/26•Bullish

    Cencora stock pre-market at EUR 304.65

    Cencora stock is trading at EUR 304.65 in pre-market at Lang & Schwarz on October 16, 2026. The company is scheduled to release its fiscal fourth-quarter results on November 4, 2026...

    ad-hoc-news.de•10/16/26•Neutral

    Cencora, Inc. (COR) Stock Price, News, Quote & History

    This Yahoo Finance article provides a comprehensive overview of Cencora, Inc. (COR), including its current stock price, historical data, key financial metrics...

    Yahoo! Finance Canada•10/15/26•Neutral

    COR Valuation and Fair Value

    P/E
    19.9x
    Forward P/E
    15.7x
    EV/EBITDA
    14.7x
    P/FCF
    16.2x
    PEG
    0.7x
    P/B
    21.6x
    See GNG's fair value

    COR Profitability: Margins, ROIC and FCF

    Gross margin
    4.0%
    Operating margin
    1.4%
    Net margin
    0.8%
    ROIC
    20.0%
    ROE
    96.9%
    FCF margin
    1.2%
    FCF yield
    6.2%

    COR Competitors

    CompanyTicker
    Cigna CorpCI
    Boston Scientific CorpBSX
    Regeneron Pharmaceuticals IncREGN
    Takeda Pharmaceutical Co Ltd ADRTAK
    Moderna IncMRNA
    Cardinal Health IncCAH
    Elevance Health IncELV
    Natera IncNTRA

    Sector: Healthcare

    COR Analyst Ratings

    Consensus
    Buy
    Analysts
    14
    Strong Buy
    4
    Buy
    7
    Hold
    3
    Sell
    0
    Strong Sell
    0

    COR Bull Case vs Bear Case

    Bull case

    • COR earns a 20.0% return on invested capital.
    • COR beat EPS estimates in 100.0% of its last 8 reported quarters.
    • 78.6% of COR's analyst ratings are Buy or Strong Buy.

    Bear case

    • COR has a debt-to-equity ratio of 3.8x.

    COR Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    3.4%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $4.76

    COR Dividend

    Forward yield
    0.7%
    Payout ratio
    9.6%
    3Y DPS growth
    6.5%
    5Y DPS growth
    -19.3%
    Pay months
    Mar, Jun, Aug, Dec
    COR dividend history

    Frequently Asked Questions About COR

    What is COR's current dividend yield?

    Cencora Inc. (COR) has a forward dividend yield of 0.70%.

    Does COR pay dividends?

    Yes, Cencora Inc. pays dividends with a forward dividend yield of 0.70%.

    What is COR's P/E ratio?

    Cencora Inc. has a price-to-earnings (P/E) ratio of 19.90.

    What is COR's market cap?

    Cencora Inc. (COR) has a market capitalization of $64.15B with a current stock price of $341.28.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In